Type 1 Helper T Cells and FoxP3-positive T Cells in HIV-Tuberculosis-associated Immune Reconstitution Inflammatory Syndrome

被引:121
作者
Meintjes, Graerne [1 ,2 ,3 ]
Wilkinson, Katalin Andrea [1 ,2 ,4 ]
Rangaka, Molebogeng Xheedla [1 ,2 ]
Skolimowska, Keira [3 ,5 ]
Van Veen, Kerryn [1 ,2 ]
Abrahams, Musaed [6 ]
Seldon, Ronnett [1 ,2 ]
Pepper, Dorninique J. [1 ,2 ,3 ]
Rebe, Kevin [3 ]
Mouton, Priscilla [1 ,2 ]
Van Cutsem, Gilles [7 ]
Nicol, Mark Patrick [1 ,2 ]
Maartens, Gary [1 ,2 ,8 ]
Wilkinson, Robert John [1 ,2 ,3 ,4 ,5 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa
[2] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa
[3] GF Jooste Hosp, Manenberg, South Africa
[4] Natl Inst Med Res, London NW7 1AA, England
[5] Univ London Imperial Coll Sci Technol & Med, Div Med, London, England
[6] Prov Adm Western Cape, Khayelitsha, South Africa
[7] Med Sans Frontieres, Khayelitsha, South Africa
[8] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Cape Town, South Africa
基金
英国医学研究理事会; 英国惠康基金;
关键词
tuberculosis; HIV; immune reconstitution inflammatory syndrome; FoxP3; type 1 helper T cells;
D O I
10.1164/rccm.200806-858OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: Tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) induced by combination antiretroviral therapy (cART) has been attributed to dysregulated expansion of tuberculin IPPD-specific IFN-gamma-secreting CD4(+) T cells. Objectives: To investigate the role of type I helper T cell expansions and regulatory T cells in HIV-TB IRIS. Methods: Longitudinal and cross-sectional studies of Mycobacterium tuberculosis-specific IFN-gamma enzyme-linked immunospot responses and flow cytometric analysis of blood cells from a total of 129 adults with HIV-1-associated tuberculosis, 98 of whom were prescribed CART. Measurements and Main Results: In cross-sectional analysis the frequency of IFN-gamma-secreting T cells recognizing early secretory antigenic target (ESAT)-6, alpha-crystallins 1 and 2, and PPD of M. tuberculosis was higher in patients with TB-IRIS than in similar patients treated for both HIV-1 and tuberculosis who did not develop IRIS (non-IRIS; P <= 0.03). The biggest difference was in the recognition of alpha-crystallin molecules: peptide mapping indicated a polyclonal response. Flow cytometric analysis indicated equal proportions of CD4(+) and CD8(+) cells positive for activation markers HLA-DIR and CD71 in both patients with TB-IRIS and non-IRIS patients. The percentage of CD4(+) cells positive for FoxP3 (Forkhead box P3) was low in both groups (TB-IRIS, 5.3 +/- 4.5; non-IRIS, 2.46 +/- 2.46; P = 0.13). Eight weeks of longitudinal analysis of patients with tuberculosis who were starting CART showed dynamic changes in antigen-specific IFN-gamma-secreting T cells in both the TB-IRIS and non-IRIS groups: the only significant trend was an increased response to PPD in the TB-IRIS group (P = 0.041). Conclusions: There is an association between helper T-cell type 1 expansions and TB-IRIS, but the occurrence of similar expansions in non-IRIS brings into question whether these are causal. The defect in immune regulation responsible for TB-IRIS remains to be fully elucidated.
引用
收藏
页码:1083 / 1089
页数:7
相关论文
共 39 条
[1]  
[Anonymous], CATAL TODAY, DOI DOI 10.1016/J.CATTOD.2022.04.013
[2]   Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].
Autran, B ;
Carcelain, G ;
Li, TS ;
Blanc, C ;
Mathez, D ;
Tubiana, R ;
Katlama, C ;
Debre, P ;
Leibowitch, J .
SCIENCE, 1997, 277 (5322) :112-116
[3]   Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study [J].
Badri, M ;
Wilson, D ;
Wood, R .
LANCET, 2002, 359 (9323) :2059-2064
[4]   Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients [J].
Bourgarit, A ;
Carcelain, G ;
Martinez, V ;
Lascoux, C ;
Delcey, V ;
Gicquel, B ;
Vicaut, E ;
Lagrange, PH ;
Sereni, D ;
Autran, B .
AIDS, 2006, 20 (02) :F1-F7
[5]   Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection [J].
Breen, RAM ;
Smith, CJ ;
Bettinson, H ;
Dart, S ;
Bannister, B ;
Johnson, MA ;
Lipman, MCI .
THORAX, 2004, 59 (08) :704-707
[6]   Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries [J].
Brinkhof, Martin W. G. ;
Egger, Matthias ;
Boulle, Andrew ;
May, Margaret ;
Hosseinipour, Mina ;
Sprinz, Eduardo ;
Braitstein, Paula ;
Dabis, Francois ;
Reiss, Peter ;
Bangsberg, David R. ;
Rickenbach, Martin ;
Miro, Jose M. ;
Myer, Landon ;
Mocroft, Amanda ;
Nash, Denis ;
Pascoe, Margaret ;
van der Borght, Stefaan ;
Schechter, Mauro .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (11) :1518-1521
[7]   Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts [J].
Brock, L ;
Weldingh, K ;
Lillebaek, T ;
Follmann, F ;
Andersen, P .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (01) :65-69
[8]   Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa [J].
Coetzee, D ;
Hildebrand, K ;
Boulle, A ;
Maartens, G ;
Louis, F ;
Labatala, V ;
Reuter, H ;
Ntwana, N ;
Goemaere, E .
AIDS, 2004, 18 (06) :887-895
[9]   Enhanced ex vivo stimulation of Mycobacterium tuberculosis-specific T cells in human immunodeficiency virus-infected persons via antigen delivery by the Bordetella pertussis adenylate cyclase vector [J].
Connell, Tom G. ;
Shey, Muki S. ;
Seldon, Ronnett ;
Rangaka, Molebogeng X. ;
van Cutsem, Gilles ;
Simsova, Marcela ;
Marcekova, Zuzana ;
Sebo, Peter ;
Curtis, Nigel ;
Diwakar, Lavanya ;
Meintjes, Graeme A. ;
Leclerc, Claude ;
Wilkinson, Robert J. ;
Wilkinson, Katalin A. .
CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (07) :847-854
[10]   Immune reconstitution inflammatory syndrome in HIV-Infected patients receiving Antiretroviral therapy - Pathogenesis, clinical manifestations and management [J].
Dhasmana, Devesh J. ;
Dheda, Keertan ;
Ravn, Pernille ;
Wilkinson, Robert J. ;
Meintjes, Graeme .
DRUGS, 2008, 68 (02) :191-208